Clinical Trial Update: Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating the combination of tipifarnib and gemcitabine hydrochloride in women with metastatic (Stage IV) breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Carcinoma, Stage IV Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED